Nitinol Commercialization Accelerator
Nitinol commercialization accelerator (NCA) has been organized through a $10 million investment by the State of Ohio Wright Project Center, the Cleveland Clinic, NASA Glenn Research Center, Norman Noble Inc., the University of Toledo, and Case Western Reserve University. The Nitinol commercialization accelerator is dedicated to the development and commercialization of Nitinol products, and will be located at facilities such as Case Institute of Technology, the Cleveland Clinic, and the University of Toledo.
The center houses the capital equipment needed to overcome the particular challenges that face Nitinol product designers in all phases of commercialization, thereby giving Ohio a competitive advantage in this growing market. The collaborators in the NCA represent some the nation's best expertise in the areas relative to Nitinol product innovation - Nitinol alloy development, Nitinol device fabrication, medical device design, aerospace, and materials science. Utilizing the new equipment purchased, NCA scientists and engineers pool their talent and resources in a comprehensive, proactive, and focused approach to Nitinol design that should bring new alloys and new products to market within the next few years.
What we can do for you:
The partners of the nitinol commercialization accelerator are committed to helping you take your ideas and bring them to reality. We can work with you to provide assistance on projects involving nitinol device development and manufacture. Our team is comprised of some of the nation’s best experts in nitinol research and product innovation. Let us help you bring your idea to life.